| Description |
1 online resource. |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Series |
Cancer Etiology, Diagnosis, and Treatments.; Pharmacology-Research, Safety Testing, and Regulation |
|
Nova Biomedical |
|
Cancer etiology, diagnosis, and treatments.
|
| Bibliography |
Includes bibliographical references and index. |
| Contents |
THE EASY BOOK OF CANCER PHARMACOLOGY; THE EASY BOOK OF CANCER PHARMACOLOGY; Library of Congress Cataloging-in-Publication Data; CONTENTS; FOREWORD; PREFACE; Chapter 1: ABIRATERONE: ABIRATERONE ACETATE: CB7630: ZYTIGA®; ABSTRACT; INTRODUCTION; CLINICAL PHARMACOLOGY; Drug Classification; Mechanism of Action; Pharmacokinetics [2]; Mechanism of Resistance; Indications [2]; Dosages; Methods of Preparation/Administration; Special Information and Cautions [2]; Contraindications; Elderly Patients; Pediatric Patients; Renal Impairment; Hepatic Impairment; Immunisations; Warnings [2] |
|
Mineralocorticoid ExcessAdrenocortical Insufficiency; Hepatotoxicity; Food Effect; Toxicities [2]; Dose Modifications [2]; Interactions [2]; CONCLUSION; REFERENCES; Chapter 2: ALBUMIN-BOUND (NAB) PACLITAXEL, ABRAXANE® ; ABSTRACT; INTRODUCTION; CLINICAL PHARMACOLOGY; Drug Classification; MECHANISM OF ACTION; Pharmacokinetics; INDICATIONS; Metastatic Breast Cancer; Metastatic Pancreatic Adenocarcinoma; Dosages; METHODS OF PREPARATION/ADMINISTRATION; SPECIAL INFORMATION AND CAUTIONS; Contraindications; Elderly; Pediatric; Renal; Hepatic; Immunisations; Pregnancy; Breast-Feeding |
|
TOXICITIES [9, 10]Dose Modifications; INTERACTIONS; CONCLUSION; REFERENCES; Chapter 3: AFLIBERCEPT. ZALTRAP®; ABSTRACT; INTRODUCTION; CLINICAL PHARMACOLOGY; Drug Classification; MECHANISM OF ACTION; MECHANISM OF RESISTANCE; PHARMACOKINETICS [6]; INDICATIONS; DOSAGES; METHODS OF PREPARATION/ADMINISTRATION [6]; SPECIAL INFORMATION AND CAUTIONS [6]; Contraindications; Elderly Patients; Pediatric Patients; Renal Impairment; Hepatic Impairment; WARNINGS [6]; Hemorrhage; Gastrointestinal Perforation; Compromised Wound Healing; Fistula Formation; Hypertension; Arterial Thromboembolic Events |
|
ProteinuriaNeutropenic Complications; Diarrhea and Dehydration; Pregnancy and Nursing; Immunisations; TOXICITIES; DOSE MODIFICATIONS; INTERACTIONS; CONCLUSION; REFERENCES; Chapter 4: AXITINIB. INLYTA®; ABSTRACT; INTRODUCTION; CLINICAL PHARMACOLOGY; Drug Classification; Mechanism of Action; Pharmacokinetics [2, 3]; Mechanism of Resistance [3]; Indications; Dosage; Methods of Preparation/Administration [1]; Special Information and Cautions [1]; Contraindications; Elderly; Pediatric; Renal Impairment; Hepatic Impairment; Breast-Feeding; Pregnancy; Immunisations; Warnings [1]; Hypertension |
|
Thromboembolic EventsHemorrhagic Events; Toxicities [1]; Dose Modifications [1]; Hepatic Impairment; Concomitant Strong CYP3A4/5 Inhibitors; Concomitant Strong CYP3A4/5 Inducers; Interactions [1]; CYP3A4/5 Inhibitors; CYP1A2 and CYP2C19 Inhibitors; CYP3A4/5 Inducers; CONCLUSION; REFERENCES; Chapter 5: BEVACIZUMAB. AVASTIN®; ABSTRACT; INTRODUCTION; DRUG CLASSIFICATION; MECHANISM OF ACTION; PHARMACOKINETICS; MECHANISM OF RESISTANCE; INDICATIONS [10]; DOSAGES [10] ; METHODS OF ADMINISTRATION/PREPARATION [10]; SPECIAL INFORMATION AND CAUTIONS [10]; Contraindications; Elderly Patients |
| Subject |
Cancer -- Chemotherapy.
|
|
Clinical pharmacology.
|
|
Pharmacology.
|
|
Antineoplastic Agents -- pharmacology |
|
Pharmacology, Clinical |
|
Pharmacology |
|
Cancer -- Chimiothérapie.
|
|
Pharmacologie clinique.
|
|
Pharmacologie.
|
|
pharmacology.
|
|
HEALTH & FITNESS / Diseases / General
|
|
MEDICAL / Clinical Medicine
|
|
MEDICAL / Diseases
|
|
MEDICAL / Evidence-Based Medicine
|
|
MEDICAL / Internal Medicine
|
|
Pharmacology
|
|
Clinical pharmacology
|
|
Cancer -- Chemotherapy
|
|
Antineoplastic agents
|
| Genre/Form |
Handbooks and manuals
|
| Added Author |
Cidon, Esther Una, editor.
|
| Added Title |
Cancer pharmacology |
| Other Form: |
Print version: The easy book of cancer pharmacology New York : Nova Biomedical, [2016] 9781634850384 (DLC) 2016935307 |
| ISBN |
9781634850438 (ebook) |
|
1634850432 |
|
1634850386 |
|
9781634850384 |
|
